Techniques in Gastrointestinal Endoscopy
Volume 12, Issue 2 , Pages 100-107 , April 2010

Radiofrequency ablation of Barrett's esophagus

  • David J. Frantz, MD, MS
  • ,
  • Evan S. Dellon, MD, MPH
  • ,
  • Nicholas J. Shaheen, MD, MPH

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Nicholas J. Shaheen, MD, MPH, Center for Esophageal Diseases and Swallowing, University of North Carolina School of Medicine, CB 7080, Chapel Hill, NC 27599-7080

References 

  1. Spechler SJ. Clinical practice (Barrett's Esophagus). N Engl J Med. 2002;346:836–842
  2. Abrams JA, Fields S, Lightdale CJ, et al. Racial and ethnic disparities in the prevalence of Barrett's esophagus among patients who undergo upper endoscopy. Clin Gastroenterol Hepatol. 2008;6:30–34
  3. Westhoff B, Brotze S, Weston A, et al. The frequency of Barrett's esophagus in high-risk patients with chronic GERD. Gastrointest Endosc. 2005;61:226–231
  4. Jovov B, Van Itallie CM, Shaheen NJ, et al. Claudin-18: A dominant tight junction protein in Barrett's esophagus and likely contributor to its acid resistance. Am J Physiol Gastrointest Liver Physiol. 2007;293:G1106–G1113
  5. Pohl H, Welch HG. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst. 2005;97:142–146
  6. Murray L, Romero Y. Role of obesity in Barrett's esophagus and cancer. Surg Oncol Clin North Am. 2009;18:439–452
  7. Schnell TG, Sontag SJ, Chejfec G, et al. Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia. Gastroenterology. 2001;120:1607–1619
  8. Sharma P, Falk GW, Weston AP, et al. Dysplasia and cancer in a large multicenter cohort of patients with Barrett's esophagus. Clin Gastroenterol Hepatol. 2006;4:566–572
  9. Overholt BF, Lightdale CJ, Wang KK, et al. Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: International, partially blinded, randomized phase III trial. Gastrointest Endosc. 2005;62:488–498
  10. Rastogi A, Puli S, El-Serag HB, et al. Incidence of esophageal adenocarcinoma in patients with Barrett's esophagus and high-grade dysplasia: A meta-analysis. Gastrointest Endosc. 2008;67:394–398
  11. Reid BJ, Levine DS, Longton G, et al. Predictors of progression to cancer in Barrett's esophagus: Baseline histology and flow cytometry identify low- and high-risk patient subsets. Am J Gastroenterol. 2000;95:1669–1676
  12. Eloubeidi MA, Mason AC, Desmond RA, et al. Temporal trends (1973-97) in survival of patients with esophageal adenocarcinoma in the United States: A glimmer of hope?. Am J Gastroenterol. 2003;98:1627–1633
  13. Williams VA, Watson TJ, Herbella FA, et al. Esophagectomy for high grade dysplasia is safe, curative, and results in good alimentary outcome. J Gastrointest Surg. 2007;11:1589–1597
  14. Law S: Esophagectomy without mortality: What can surgeons do? J Gastrointest Surg (in press)
  15. Goldberg SN. Radiofrequency tumor ablation: Principles and techniques. Eur J Ultrasound. 2001;13:129–147
  16. Nath S, Haines DE. Biophysics and pathology of catheter energy delivery systems. Prog Cardiovasc Dis. 1995;37:185–204
  17. Shaheen NJ, Sharma P, Overholt BF, et al. Radiofrequency ablation in Barrett's esophagus with dysplasia. N Engl J Med. 2009;360:2277–2288
  18. Fleischer DE, Overholt BF, Sharma VK, et al. Endoscopic ablation of Barrett's esophagus: A multicenter study with 2.5-year follow-up. Gastrointest Endosc. 2008;68:867–876
  19. Shaheen NJ, Sharma P, Overholt BF, et al. 213 A randomized, multicenter, sham-controlled trial of radiofrequency ablation (RFA) for subjects with Barrett's Esophagus (Be) containing dysplasia: Interim results of the Aim Dysplasia Trial. Gastroenterology. 2008;134:A-37;A37
  20. Sharma VK, Wang KK, Overholt BF, et al. Balloon-based, circumferential, endoscopic radiofrequency ablation of Barrett's esophagus: 1-year follow-up of 100 patients. Gastrointest Endosc. 2007;65:185–195
  21. Sharma VK, Jae Kim H, Das A, et al. Circumferential and focal ablation of Barrett's esophagus containing dysplasia. Am J Gastroenterol. 2009;104:310–317
  22. Pouw RE, Wirths K, Eisendrath P, et al. Efficacy of radiofrequency ablation combined with endoscopic resection for Barrett's Esophagus with early neoplasia. Clin Gastroenterol Hepatol. 2009;8:23–29
  23. Velanovich V. Endoscopic endoluminal radiofrequency ablation of Barrett's esophagus: Initial results and lessons learned. Surg Endosc. 2009;23:2175–2180
  24. Eldaif SM, Lin E, Singh KA, et al. Radiofrequency ablation of Barrett's esophagus: Short-term results. Ann Thorac Surg. 2009;87:405–410
  25. Vassiliou MC, Von Renteln D, Wiener DC, et al: Treatment of ultralong-segment Barrett's using focal and balloon-based radiofrequency ablation. Surg Endosc (in press)
  26. Ganz RA, Overholt BF, Sharma VK, et al. Circumferential ablation of Barrett's esophagus that contains high-grade dysplasia: A U.S. Multicenter Registry. Gastrointest Endosc. 2008;68:35–40
  27. Gondrie JJ, Pouw RE, Sondermeijer CM, et al. Stepwise circumferential and focal ablation of Barrett's esophagus with high-grade dysplasia: Results of the first prospective series of 11 patients. Endoscopy. 2008;40:359–369
  28. Hernandez JC, Reicher S, Chung D, et al. Pilot series of radiofrequency ablation of Barrett's esophagus with or without neoplasia. Endoscopy. 2008;40:388–392
  29. Sharma VK, Kim HJ, Das A, et al. A prospective pilot trial of ablation of Barrett's esophagus with low-grade dysplasia using stepwise circumferential and focal ablation (HALO system). Endoscopy. 2008;40:380–387
  30. Gondrie JJ, Pouw RE, Sondermeijer CM, et al. Effective treatment of early Barrett's neoplasia with stepwise circumferential and focal ablation using the HALO system. Endoscopy. 2008;40:370–379
  31. Sharma P, Wani S, Rastogi A. Endoscopic therapy for high-grade dysplasia in Barrett's esophagus: Ablate, resect, or both?. Gastrointest Endosc. 2007;66:469–474
  32. Roorda AK, Marcus SN, Triadafilopoulos G. Early experience with radiofrequency energy ablation therapy for Barrett's esophagus with and without dysplasia. Dis Esophagus. 2007;20:516–522
  33. Bronner MP, Overholt BF, Taylor SL, et al. Squamous overgrowth is not a safety concern for photodynamic therapy for Barrett's esophagus with high-grade dysplasia. Gastroenterology. 2009;136:56–64

 The authors report no direct financial interests that might pose a conflict of interest in connection with the submitted manuscript.

PII: S1096-2883(10)00016-1

doi: 10.1016/j.tgie.2010.02.005

Techniques in Gastrointestinal Endoscopy
Volume 12, Issue 2 , Pages 100-107 , April 2010